3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis

Proceedings of the National Academy of Sciences
2007.0

Abstract

3-Hydroxyanthranilic acid (HAA), a compound generated during tryptophan metabolism initiated by indoleamine 2,3-dioxygenase, is known to induce T cell death, but its molecular target is not known. Here we report that HAA inhibits NF-kappaB activation upon T cell antigen receptor engagement by specifically targeting PDK1. Inhibition of NF-kappaB by HAA leads to dysfunction and cell death of activated Th2 cells, which in turn suppresses experimental asthma. Inhibition of NF-kappaB and induction of apoptosis is specific to CD4 T cells because HAA does not inhibit NF-kappaB activation or induce cell death upon Toll-like receptor 4 stimulation in dendritic cells. Thus, HAA is a natural inhibitor that restrains T cell expansion and activation.

Knowledge Graph

Similar Paper

3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis
Proceedings of the National Academy of Sciences 2007.0
3-Hydroxyanthranilic acid, an L-tryptophan metabolite, induces apoptosis in monocyte-derived cells stimulated by interferon- γ
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 2001.0
The tryptophan metabolite 3-hydroxyanthranilic acid lowers plasma lipids and decreases atherosclerosis in hypercholesterolaemic mice
European Heart Journal 2012.0
Histone Deacetylase Inhibitors Suppress TF-κB-dependent Agonist-driven Tissue Factor Expression in Endothelial Cells and Monocytes
Journal of Biological Chemistry 2007.0
Inhibitors of NF-κB derived from thalidomide
Bioorganic & Medicinal Chemistry Letters 2007.0
Anethole blocks both early and late cellular responses transduced by tumor necrosis factor: effect on NF-κB, AP-1, JNK, MAPKK and apoptosis
Oncogene 2000.0
Indole-3-acetic Acid Antagonists of the Prostaglandin D<sub>2</sub> Receptor CRTH2
Journal of Medicinal Chemistry 2005.0
Thalidomide analogs and PDE4 inhibition
Bioorganic &amp; Medicinal Chemistry Letters 1998.0
Antiallergic Activity Profile in Vitro RBL-2H3 and in Vivo Passive Cutaneous Anaphylaxis Mouse Model of New Sila-Substituted 1,3,4-Oxadiazoles
Journal of Medicinal Chemistry 2012.0
1,3,4-Oxadiazole-Containing Histone Deacetylase Inhibitors: Anticancer Activities in Cancer Cells
Journal of Medicinal Chemistry 2014.0